Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

345 ARTÍCULOS , VIENDO DEL 61 AL 75

Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story

Stamford A, Strickland C.

Curr Opin Chem Biol. 2013 Jun;17(3):320-8. doi: 10.1016/j.cbpa.2013.04.016. Epub 2013 May 14.

Atrial flutter in a patient with Alzheimer dementia treated by rivastigmine

Hsu YC, Chao CY, Chang HA, Hwang SY, Tzeng NS.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E25-6. doi: 10.1176/appi.neuropsych.12030063.

The NLRP3 inflammasome in Alzheimer's disease

Tan MS, Yu JT, Jiang T, Zhu XC, Tan L.

Mol Neurobiol. 2013 Dec;48(3):875-82. doi: 10.1007/s12035-013-8475-x. Epub 2013 May 19.

An open-label, nonplacebo-controlled study on Cistanche tubulosa glycoside capsules (Memoregain(®)) for treating moderate Alzheimer's Disease

Guo Q, Zhou Y, Wang CJ, Huang YM, Lee YT, Su MH, Lu J.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):363-70. doi: 10.1177/1533317513488907. Epub 2013 May 17.

Prediction models for assessing long-term outcome in Alzheimer's disease: a review

Wattmo C.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):440-9. doi: 10.1177/1533317513488916. Epub 2013 May 20.

[Effectiveness and limitation of newly approved drugs for Alzheimer's disease]

Hattori H.

Seishin Shinkeigaku Zasshi. 2013;115(1):22-31.

Drug development in dementia

Cunningham EL, Passmore AP.

Maturitas. 2013 Nov;76(3):260-6. doi: 10.1016/j.maturitas.2013.04.013. Epub 2013 May 23.

Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease

Gao J, Inagaki Y, Li X, Kokudo N, Tang W.

Drug Discov Ther. 2013 Apr;7(2):46-57.

Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies

Ramachandran G, Udgaonkar JB.

Biochemistry. 2013 Jun 18;52(24):4107-26. doi: 10.1021/bi400209z. Epub 2013 Jun 6.

Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease

Igeta H, Suzuki Y, Motegi T, Sasaki A, Yokoyama Y, Someya T.

Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):680.e9-10. doi: 10.1016/j.genhosppsych.2013.04.007. Epub 2013 Jun 2.

Alzheimer's disease and frail syndrome: features overlap predictive of poor outcome

Martorana A.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):506. doi: 10.2174/18715273113129990068.

Nutritional approaches in the risk reduction and management of Alzheimer's disease

Mi W, van Wijk N, Cansev M, Sijben JW, Kamphuis PJ.

Nutrition. 2013 Sep;29(9):1080-9. doi: 10.1016/j.nut.2013.01.024. Epub 2013 Jun 4.

Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: comparison with memantine

Hemmati F, Dargahi L, Nasoohi S, Omidbakhsh R, Mohamed Z, Chik Z, Naidu M, Ahmadiani A.

Behav Brain Res. 2013 Sep 1;252:415-21. doi: 10.1016/j.bbr.2013.06.016. Epub 2013 Jun 15.

One-year repeated cycles of cognitive training (CT) for Alzheimer's disease

Bergamaschi S, Arcara G, Calza A, Villani D, Orgeta V, Mondini S.

Aging Clin Exp Res. 2013 Aug;25(4):421-6. doi: 10.1007/s40520-013-0065-2. Epub 2013 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias